Ftse Mib
33.812,44
0,12%
DAX
18.417,55
0,62%
S&P 500
5.459,10
1,11%
NASDAQ
17.357,88
1,03%
Bitcoin
67.924,18
0,02%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Sanofi (SAN) Sanofi (SAN) Notizie

Sanofi

SAN
96,82
-0,67 (-0,69%)
26 Lug 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
25/7/202416:56GLOBEPress Release: Online availability of Sanofi’s half-year..
25/7/202416:56UKREGCommuniqué de presse : Mise en ligne du rapport financier..
25/7/202416:56UKREGPress Release: Online availability of Sanofi’s half-year..
25/7/202407:30GLOBEPress Release: Sanofi Q2 - strong performance with 10% sales..
25/7/202407:30UKREGCommuniqué de presse : Forte performance au deuxième..
25/7/202407:30UKREGPress Release: Sanofi Q2 - strong performance with 10% sales..
22/7/202422:05UKREGSanofi: Informations relatives au nombre de droits de vote..
22/7/202422:05UKREGSanofi: Information concerning the total number of voting..
17/7/202423:27GLOBEPress Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3..
17/7/202423:27UKREGCommuniqué de presse : Le NEJM publie les données de phase..
17/7/202423:27UKREGPress Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3..
03/7/202407:00GLOBECommuniqué de presse : Dupixent devient le tout premier..
26/6/202423:30GLOBECommuniqué de presse : Publication dans le NEJM des données..
25/6/202419:32GLOBEPress Release: Availability of the Q2 2024 Aide-mémoire
21/6/202409:30GLOBECommuniqué de presse : Audrey Duval Derveloy nommée..
21/6/202407:00GLOBEPress Release: ISTH: Sanofi advances leadership in..
20/6/202414:00GLOBEPress Release: Sanofi and Biovac spearhead polio vaccine..
12/6/202420:19GLOBESanofi: Informations relatives au nombre de droits de vote..
03/6/202422:15GLOBECommuniqué de presse : ASCO : Sarclisa, en association avec..
31/5/202412:00GLOBECommuniqué de presse : Sanofi lance son plan mondial 2024..
31/5/202407:05GLOBEPress Release: Dupixent recommended for EU approval by the..
31/5/202407:00GLOBEPress Release: Update on FDA priority review of Dupixent for..
30/5/202415:01GLOBEPress Release: Sanofi completes acquisition of Inhibrx, Inc.
27/5/202407:00GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
21/5/202407:30GLOBECommuniqué de presse : Sanofi, Formation Bio et OpenAI..
20/5/202422:54GLOBESanofi: Information concerning the total number of voting..
20/5/202420:15GLOBECommuniqué de presse : Présentation à l’ATS et publication..
13/5/202407:00GLOBECommuniqué de presse : Sanofi investit plus d’un milliard..
10/5/202408:00GLOBECommuniqué de presse : Sanofi et Novavax concluent un accord..
02/5/202407:00GLOBEPress Release: Beyfortus real-world evidence published in..
30/4/202418:00GLOBEPress Release: Annual General Meeting of April 30, 2024
25/4/202407:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/4/202407:00GLOBECommuniqué de presse : L’étude de phase III LUNA 3 du..
17/4/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II à..
12/4/202420:05GLOBESanofi: Informations relatives au nombre de droits de vote..
08/4/202418:00GLOBESanofi - AGM 30.04.2024 - Mise à disposition des documents..
22/3/202407:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
15/3/202420:04GLOBESanofi: Informations relatives au nombre de droits de vote..
11/3/202407:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
24/2/202415:51GLOBECommuniqué : Résultats de phase II montrent que le..
23/2/202418:45GLOBECommuniqué de presse : Dépôt du Document d’Enregistrement..
23/2/202407:00GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
22/2/202419:02GLOBEPress Release: Sanofi’s Board of Directors proposes the..
20/2/202423:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/2/202407:00GLOBEPress Release: Japan first in the world to approve Dupixent®..
15/2/202414:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/2/202408:00GLOBECommuniqué de presse : Entraide, conditions de travail..
01/2/202407:30GLOBECommuniqué de presse : François-Xavier Roger nommé Directeur..
25/1/202420:30GLOBEPress Release: Dupixent® FDA approved as first and only..
23/1/202412:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
Apertura: 97,49 Min: 95,50 Max: 97,59
Chiusura: 97,49

La tua Cronologia

EU
SAN
Sanofi
NYSE
FNB
FNB
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network